Precongress Course 4
Special Interest Groups Ethics and Law and Safety and Quality in ART
Heidi Mertes (SIG Ethics and Law), Kelly Tilleman (SIG Safety and Quality in ART)
Medical assisted reproduction (MAR) involves the use of drugs and the artificial development of embryos. It has been speculated that these techniques may be associated with increased levels of long-term health problems in both patients and children. Potential health risks have been suspected ever since the first IVF baby, Louise Brown, was born in the UK in 1978. As healthcare practicioner and embryologist working in MAR, on an everyday level it seems safe to use. But is it really? Aren't we sometimes executing procedures that are quite new, without reassuring followup data? This course will consider the ideal preclinical validation path of novel treatments and the long-term effect on children born as the result of established assisted reproduction as well as the health effects in patients undergoing MAR. Technical improvements in MAR pushes patients and practitionars to the limit: Carrier-screening techniques, PGT-A, mitochondrial transfer and we will debate how we might determine acceptable limits to new treatments.
Physicians, scientists, nurses and midwives, social scientists and ethicists
Educational needs and expected outcomes
At the conclusion of this course the participant should be able to:
Share this page